LewisLit
Powered by Scigenix
AI-Powered Pharmacovigilance Literature Surveillance for Africa
Precision. Efficiency. Patient Safety.
LewisLit is an advanced agentic AI solution designed specifically for pharmaceutical companies operating in Africa. Built to support cost-conscious organisations without compromising compliance, LewisLit augments both local and global literature searches — reducing manual workload by up to 80% while strengthening regulatory oversight.
At its core, LewisLit combines intelligent automation with expert human oversight, enabling efficient, compliant surveillance of scientific literature for potential adverse events linked to pharmaceutical products.
Why LewisLit?
Pharmacovigilance teams face increasing regulatory expectations, growing publication volumes, and limited regional coverage from global solutions. LewisLit addresses these challenges with an Africa-focused, compliance-driven approach.
Why LewisLit?
- Human-in-the-loop workflow ensuring expert validation
- Alignment with EMA GVP Module VI
- Compliance with African PV regulations
- Coverage of 110+ journals across 8+ African countries
- Direct API integration with PubMed
- Full audit trail for inspection readiness
100% Automated Literature Detection
LewisLit automatically identifies and ingests all relevant published literature within the defined screening period.
This means
- Zero manual effort in literature detection
- Reduced risk of missed publications
- Greater operational consistency and traceability
Your team focuses on strategic safety assessment — not manual journal scanning.
A Smarter Literature Surveillance Workflow
LewisLit transforms the traditional PV literature process through four integrated innovations:
Data Input
Seamless ingestion of literature from PubMed and non-indexed African medical journals.Daily updates ensure complete coverage.
AI Analysis
Advanced NLP and AI models detect potential reportable adverse events, matching AEs across titles, abstracts, and full text articles.
Event Detection
Intelligent flagging system minimizes risk through maximizing negative predictive value, increasing true negatives.
Compliance Reporting
• FDA 21 CFR Part 11–guided validation
• EMA GVP Module VI-compliant reports generated automatically.
A Smarter Literature Surveillance Workflow
LewisLit bridges the gap between global pharmacovigilance standards and African regulatory realities — delivering scalable, compliant, and inspection-ready literature surveillance.
Interested in seeing LewisLit in action? Contact us today to book a personalised demo and explore how AI-powered literature surveillance can strengthen your pharmacovigilance workflows.